全文获取类型
收费全文 | 262篇 |
免费 | 14篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 9篇 |
妇产科学 | 6篇 |
基础医学 | 58篇 |
口腔科学 | 3篇 |
临床医学 | 19篇 |
内科学 | 64篇 |
皮肤病学 | 10篇 |
神经病学 | 12篇 |
特种医学 | 1篇 |
外科学 | 24篇 |
综合类 | 2篇 |
预防医学 | 38篇 |
眼科学 | 1篇 |
药学 | 9篇 |
肿瘤学 | 20篇 |
出版年
2023年 | 2篇 |
2022年 | 2篇 |
2021年 | 10篇 |
2020年 | 6篇 |
2019年 | 7篇 |
2018年 | 9篇 |
2017年 | 12篇 |
2016年 | 9篇 |
2015年 | 7篇 |
2014年 | 6篇 |
2013年 | 15篇 |
2012年 | 17篇 |
2011年 | 24篇 |
2010年 | 7篇 |
2009年 | 10篇 |
2008年 | 21篇 |
2007年 | 14篇 |
2006年 | 17篇 |
2005年 | 16篇 |
2004年 | 10篇 |
2003年 | 15篇 |
2002年 | 15篇 |
2001年 | 9篇 |
2000年 | 4篇 |
1997年 | 1篇 |
1996年 | 1篇 |
1994年 | 1篇 |
1991年 | 1篇 |
1989年 | 3篇 |
1983年 | 1篇 |
1979年 | 1篇 |
1978年 | 2篇 |
1975年 | 1篇 |
1974年 | 1篇 |
1967年 | 1篇 |
1966年 | 1篇 |
排序方式: 共有279条查询结果,搜索用时 15 毫秒
1.
Riera-Espinoza G Ramos J Carvajal R Belzares E Stanbury G Farías R Valderrama I Alvarez K Riera-González G 《Maturitas》2004,47(2):83-90
OBJECTIVES: An open study was carried out to evaluate changes in bone remodeling markers such as N-telopeptide (NTx), tartrate-resistant acid phosphatase (TRAP), total alkaline phosphatase (TAP), and bone alkaline phosphatase (BAP) during a 1-year continuous tibolone treatment in postmenopausal women. MATERIAL AND METHODS: Thirty-six postmenopausal women were recruited for receiving tibolone 2.5 mg per day for 1 year. Densitometry and determination of biochemical markers of bone metabolism in serum and urine were performed at 1, 3, 6, and 12 months. RESULTS: Comparing baseline with 12 month's values, BAP and all resorption markers decreased significantly. NTx began to decrease since the initiation of the treatment (baseline: 74.4 +/- 5.3; 1 month: 57.5 +/- 4.2; 12 months: 36.6 +/- 2.8). BAP increased at the first month (baseline: 37.3 +/- 2.1; 1 month: 42.6 +/- 3.0) but diminished in the following months (12 months: 23.1 +/- 1.5). TAP started to decrease significantly only after 6 months of treatment (baseline: 37.3 +/- 2.1; 12 months: 31.4 +/- 2.3) and TRAP after 3 months (baseline: 9.8 +/- 0.4; 6 months: 9.1 +/- 0.5; 12 months: 8.2 +/- 0.4). Normal bone mineral density at distal and ultradistal forearm was maintained during the 1-year treatment (baseline: 0.42 +/- 0.01; 12 months: 0.42 +/- 0.01 and baseline: 0.33 +/- 0.01; 12 months: 0.33 +/- 0.01, respectively). CONCLUSION: The use of tibolone 2.5 mg per day diminished progressively and significantly bone resorption and formation markers during 1-year treatment period. 相似文献
2.
3.
Suzanne E. Mitchell Morgan Mako Ekaterina Sadikova Linda Barnes Abriella Stone Milagros C. Rosal John Wiecha 《Journal of diabetes science and technology》2014,8(6):1185-1192
The purpose was to characterize participants’ experiences of a diabetes self-management (DSM) education program delivered via a virtual world (VW) versus a face-to-face (F2F) format. Participants included a randomly selected sample of participants who completed the Women in Control study. Four focus groups were conducted with 32 participants. Four researchers coded the data and conducted a qualitative thematic analysis. Four overarching themes were identified. Three domains apply to both VW and F2F formats, including (1) the value of DSM knowledge gained, (2) cultivating DSM attitudes and skills, and (3) the value of peer-derived social support. The fourth domain is labeled positive technological development for DSM (VW condition only). VW and F2F groups both reported mastery of DSM knowledge, attitudes, and skills, and there were no differences in peer-derived social support between groups. The technological aspects of VW participation afforded VW participants a unique sense of personal agency and diabetes self-efficacy not reported by F2F participants. DSM education in a VW is feasible and educational outcomes are similar to a F2F classroom experience. Furthermore, learning DSM skills in a VW offers unique advantages in supporting personal agency for health behavior change. Further research is warranted. 相似文献
4.
5.
6.
Growth hormone releasing peptide (ghrelin) is synthesized and secreted by cardiomyocytes 总被引:5,自引:0,他引:5
Iglesias MJ Piñeiro R Blanco M Gallego R Diéguez C Gualillo O González-Juanatey JR Lago F 《Cardiovascular research》2004,62(3):481-488
OBJECTIVE: Ghrelin, the endogenous ligand of growth hormone secretagogue receptor (GHS-R), acts on the pituitary and the hypothalamus to stimulate the release of growth hormone (GH) and promotes appetite and adiposity. It has also been reported to increase myocardial contractility, induce vasodilation, and protect against myocardial-infarction-induced heart failure. Though principally gastric in origin, it is also produced by other tissues. This work investigated whether cardiomyocytes synthesize and secrete ghrelin, and how its production in these cells responds to stress and exogenous apoptotic agents. METHODS: Ghrelin and its receptor expression was studied by RT-PCR, immunohistochemistry, and competitive binding studies in mouse adult cardiomyocyte cell line HL-1, and primary cultured human cardiomyocytes. Ghrelin accumulation in cardiomyocyte culture medium was measured by radioimmunoassay. Viability and apoptosis assays were carried on by MTT and Hoechst dye vital staining, respectively. RESULTS: RT-PCR showed that HL-1 cells produce mRNAs for both ghrelin and GHS-R, and that GHS-R1a is expressed in human cardiomyocytes; and competitive binding studies using (125)I-labelled ghrelin showed efficient constitutive expression of GHS-R at the surface of HL-1 cells. Immunohistochemistry confirmed the presence of ghrelin in the cytoplasm of HL-1 cells and of isolated human cardiomyocytes in primary culture. Radioimmunoassay showed that ghrelin was secreted by HL-1 cells and human cardiomyocytes into the culture medium. Ghrelin did not modify the viability of HL-1 cells subjected to 12-h starvation, but did protect against the apoptosis inducer cytosine arabinoside (AraC). Finally, production of ghrelin mRNA in HL-1 cardiomyocytes was reduced by AraC but increased if exposure to AraC was preceded by GH treatment. CONCLUSIONS: Ghrelin is synthesized and secreted by isolated murine and human cardiomyocytes, probably with paracrine/autocrine effects, and may be involved in protecting these cells from apoptosis. 相似文献
7.
8.
Ximena Calderón‐Castrat M.D. Rosa Castro M.D. Johanna Peceros‐Escalante M.D. Marjorie Villate Caballero M.D. Cesar Chian M.D. Rosalía Ballona M.D. 《Pediatric dermatology》2017,34(3):e109-e115
Pediatric Degos disease is rare, with only 36 cases reported in the medical literature. Classically the diagnosis has been established according to pathognomonic histopathologic findings, but when these features are not present, there may be a delay in diagnosis. We report the second congenital case of Degos disease, highlighting the clinical and dermoscopic findings. 相似文献
9.
10.